DB05738ExperimentalSmall molecule
Vapitadine is an antihistamine that Barrier Therapeutics is developing as a treatment for allergic reactions of the skin, such as those associated with hives and for the itch associated with... An advantage of vapitadine over other antihistamines may be the absence of the sedation, even at high doses.
- Mechanism
- Curator reviewed
Pharmacologically active on Histamine H1 receptor
- Primary indication
- Investigated for use/treatment in atopic dermatitis.Curator reviewed
- Formula / weight
- C17H20N4O · 296.374 g/mol (avg)
Resolves to
Structure
InChIKey
VQWGYPVNVICKFC-UHFFFAOYSA-NSMILESNC(=O)C1=CN=C2N1CCC1=C(C=CC=C1)C21CCNCC1Targets
What you can answer from here — as of September 13, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Vapitadine, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account